The nice people at Stago sent their newsletter today.
The role of thrombin generation potential in identifying breast cancer patients who are at a high risk of early disease recurrence, requests for topics for future educational seminars, the latest ASH guidelines…
Something for nothing is all good stuff.
No comments:
Post a Comment